Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis
Abstract Objective It is unknown whether there are differences in efficacy and safety between quetiapine extended‐release, 300 mg/d (QUEXR300), and olanzapine, 5‐20 mg/d (OLA), for Japanese patients with bipolar depression. Methods We conducted a Bayesian analysis of data from phase 3 studies in Jap...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-09-01
|
| Series: | Neuropsychopharmacology Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/npr2.12070 |